Carla Casulo, MD, on Follicular Lymphoma: Results From the FLASH Study

2017 ASH Annual Meeting
Tweet this page

Carla Casulo, MD, of the James P. Wilmot Cancer Center, discusses findings on POD24 as a robust early clinical endpoint of poor survival in follicular lymphoma, using data from more than 5,000 patients in 13 clinical trials (Abstract 412).

Advertisement

Advertisement



Advertisement